What’s really at stake when a biotech startup tries to bring something new into the world?In this episode, I speak with Dr. Hans Sauer, Deputy General Counsel and Vice President for Intellectual Property at the Biotechnology Innovation Organization (BIO) and adjunct professor of law at Georgetown Law School. With a legal and scientific career spanning biotech patents, policy, and entrepreneurship, Dr. Sauer shares a big-picture view of what’s working—and what’s still unfolding—in today’s biotech landscape.We talk about the key legal and ethical questions facing biotech startups, how intellectual property influences innovation, and how the biotech sector is pushing law and policy to evolve. It’s a wide-ranging and grounded conversation about the real frameworks that shape biotech outcomes.

Ver todos los episodios